Cargando…

Bevacizumab Plays a double-edged role in Neoadjuvant Therapy for Non-metastatic Breast Cancer: A Systemic Review and Meta-Analysis

The anti-angiogenic drug Bevacizumab (Bev) is engaged in neoadjuvant therapy for non-metastatic breast cancer (NMBC). However, whether neoadjuvant Bev providing a greater benefit to patients is debatable. Our study aimed to review Bev's role in Neoadjuvant therapy (NAT) in NMBC and identify pre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, XinJie, Gao, Yu, Zhang, GanLin, Li, BingXue, Ma, TingTing, Ma, YunFei, Wang, XiaoMin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040714/ https://www.ncbi.nlm.nih.gov/pubmed/33854624 http://dx.doi.org/10.7150/jca.53303

Ejemplares similares

Nanoparticle albumin-bound paclitaxel versus solvent-based paclitaxel in breast cancer: A protocol for systemic review and meta-analysis
por: Li, Bingxue, et al.
Publicado: (2021)

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer
por: Wan, Guoxing, et al.
Publicado: (2019)

Identification of Hub Genes and Small Molecule Drugs Associated with Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer
por: Li, Guangda, et al.
Publicado: (2021)

Autophagy plays a double-edged sword role in liver diseases
por: Zhou, Jing-chao, et al.
Publicado: (2021)

Granulomatosis with polyangitis with mononeuritis multiplex-immunosuppressives playing a double-edged sword
por: Mukherjee, Subhasis, et al.
Publicado: (2014)

The effect of traditional Chinese medicine treatment for post-viral olfactory dysfunction: A protocol for systematic review and meta-analysis
por: Ma, Fangfang, et al.
Publicado: (2021)

Is It Still Double Edged? Not for University Students’ Development of Moral Reasoning and Video Game Play
por: Hodge, Sarah E., et al.
Publicado: (2020)

Calcium Plays a Double-Edged Role in Modulating Cadmium Uptake and Translocation in Rice
por: Zhang, Shuo, et al.
Publicado: (2020)

TAS-102 Monotherapy and Combination Therapy with Bevacizumab for Metastatic Colorectal Cancer
por: Liu, Cheng-Jiang, et al.
Publicado: (2021)

Comparison of Neoadjuvant Chemotherapy Efficiency in Advanced Ovarian Cancer Patients Treated With Paclitaxel Plus Carboplatin and Intraperitoneal Bevacizumab vs. Paclitaxel With Carboplatin
por: Tao, Yin, et al.
Publicado: (2022)

Insulin for the treatment of hyperkalemia: a double-edged sword?
por: Li, Tingting, et al.
Publicado: (2014)

Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma
por: Zhou, Ting, et al.
Publicado: (2022)

Double-edged sword.
Publicado: (1994)

Transcatheter Tricuspid and Mitral Valve Edge-to-Edge Repair: The Double Double Orifice
por: Bechis, Mary Z., et al.
Publicado: (2018)

Correlation of bevacizumab-induced hypertension and outcomes of metastatic colorectal cancer patients treated with bevacizumab: a systematic review and meta-analysis
por: Cai, Jun, et al.
Publicado: (2013)

Stem Cells Inhibition by Bevacizumab in Combination with Neoadjuvant Chemotherapy for Breast Cancer
por: Sabatier, Renaud, et al.
Publicado: (2019)

Doubling the Dose of Bevacizumab Beyond Progression in Metastatic Colorectal Cancer–the Experience of a Tertiary Cancer Center
por: Căinap, Călin, et al.
Publicado: (2021)

Astrocytes: a double-edged sword in neurodegenerative diseases
por: Ding, Zhi-Bin, et al.
Publicado: (2021)

Efficacy of Bevacizumab Combined with Pemetrexed in the Treatment of Recurrent and Metastatic Cervical Cancer
por: He, Ying, et al.
Publicado: (2022)

Bevacizumab in the therapy for refractory metastatic colorectal cancer
por: Mulcahy, Mary F
Publicado: (2008)

Is Greed a Double-Edged Sword? The Roles of the Need for Social Status and Perceived Distributive Justice in the Relationship Between Greed and Job Performance
por: Zhu, Yiming, et al.
Publicado: (2019)

Double-edged Gadd45
por: Powell, Kendall
Publicado: (2005)

The double-edged sword of evolution
por: Kruzel-Davila, Etty, et al.
Publicado: (2017)

A double-edged sword
por: Vandebotermet, Martijn, et al.
Publicado: (2020)

The double-edged functions of necroptosis
por: Ye, Keng, et al.
Publicado: (2023)

Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials
por: Cao, Li, et al.
Publicado: (2015)

The double-edged helix : science in the real world /
por: Cavalieri, Liebe F., 1919-

Neoadjuvant bevacizumab persistently inactivates VEGF at the time of surgery despite preoperative cessation
por: Starlinger, P, et al.
Publicado: (2012)

It’s Double Edged: The Positive and Negative Relationships Between the Development of Moral Reasoning and Video Game Play Among Adolescents
por: Hodge, Sarah E., et al.
Publicado: (2019)

The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
por: Yin, Chenxi, et al.
Publicado: (2016)

Diagnostic Accuracy of Methylated SEPT9 for Blood-based Colorectal Cancer Detection: A Systematic Review and Meta-Analysis
por: Nian, Jiayun, et al.
Publicado: (2017)

A double-edged sword: ROS related therapies in the treatment of psoriasis
por: Hu, Jingyi, et al.
Publicado: (2022)

A Double-Edged Sword—Cardiovascular Concerns of Potential Anti-COVID-19 Drugs
por: Yu, Wen-Liang, et al.
Publicado: (2020)

Mode Conversion of the Edge Modes in the Graphene Double-Ribbon Bend
por: Zhang, Lanlan, et al.
Publicado: (2019)

Bevacizumab increases the risk of anastomosis site leakage in metastatic colorectal cancer
por: Kim, Seijong, et al.
Publicado: (2022)

Critical appraisal of bevacizumab in the treatment of metastatic colorectal cancer
por: Zoratto, Federica, et al.
Publicado: (2012)

Modeling Efficacy of Bevacizumab Treatment for Metastatic Colon Cancer
por: Islam, Rezwan, et al.
Publicado: (2013)

Bevacizumab treatment in the elderly patient with metastatic colorectal cancer
por: Di Bartolomeo, Maria, et al.
Publicado: (2015)

FOLFOX‐bevacizumab chemotherapy in patients with metastatic neuroendocrine tumors
por: Lacombe, Caroline, et al.
Publicado: (2023)

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vmsg4i1g6j87cjdphs8jd5t8v7